Metal  ||| S:0 E:6 ||| NNP
chaperones  ||| S:6 E:17 ||| FW
prevent  ||| S:17 E:25 ||| FW
zinc-mediated  ||| S:25 E:39 ||| FW
cognitive  ||| S:39 E:49 ||| FW
decline  ||| S:49 E:57 ||| FW
Zinc  ||| S:57 E:62 ||| FW
transporter-3  ||| S:62 E:76 ||| FW
( ||| S:76 E:77 ||| -LRB-
ZnT3 ||| S:77 E:81 ||| NNP
)  ||| S:81 E:83 ||| -RRB-
protein  ||| S:83 E:91 ||| NN
is  ||| S:91 E:94 ||| VBZ
responsible  ||| S:94 E:106 ||| JJ
for  ||| S:106 E:110 ||| IN
loading  ||| S:110 E:118 ||| JJ
zinc  ||| S:118 E:123 ||| NN
into  ||| S:123 E:128 ||| IN
presynaptic  ||| S:128 E:140 ||| JJ
vesicles  ||| S:140 E:149 ||| NN
and  ||| S:149 E:153 ||| CC
consequently  ||| S:153 E:166 ||| RB
controls  ||| S:166 E:175 ||| VBZ
the  ||| S:175 E:179 ||| DT
availability  ||| S:179 E:192 ||| NN
of  ||| S:192 E:195 ||| IN
zinc  ||| S:195 E:200 ||| NN
at  ||| S:200 E:203 ||| IN
the  ||| S:203 E:207 ||| DT
glutamatergic  ||| S:207 E:221 ||| JJ
synapse ||| S:221 E:228 ||| NN
.  ||| S:228 E:230 ||| .
ZnT3  ||| S:230 E:235 ||| NNP
has  ||| S:235 E:239 ||| VBZ
been  ||| S:239 E:244 ||| VBN
shown  ||| S:244 E:250 ||| VBN
to  ||| S:250 E:253 ||| TO
decline  ||| S:253 E:261 ||| VB
with  ||| S:261 E:266 ||| IN
age  ||| S:266 E:270 ||| NN
and  ||| S:270 E:274 ||| CC
in  ||| S:274 E:277 ||| IN
Alzheimer ||| S:277 E:286 ||| NNP
's  ||| S:286 E:289 ||| POS
disease  ||| S:289 E:297 ||| NN
( ||| S:297 E:298 ||| -LRB-
AD ||| S:298 E:300 ||| NNP
)  ||| S:300 E:302 ||| -RRB-
and  ||| S:302 E:306 ||| CC
is  ||| S:306 E:309 ||| VBZ
crucially  ||| S:309 E:319 ||| RB
involved  ||| S:319 E:328 ||| VBN
in  ||| S:328 E:331 ||| IN
learning  ||| S:331 E:340 ||| VBG
and  ||| S:340 E:344 ||| CC
memory ||| S:344 E:350 ||| NN
.  ||| S:350 E:352 ||| .
In  ||| S:352 E:355 ||| IN
this  ||| S:355 E:360 ||| DT
study ||| S:360 E:365 ||| NN
,  ||| S:365 E:367 ||| ,
we  ||| S:367 E:370 ||| PRP
utilised  ||| S:370 E:379 ||| VBP
whole  ||| S:379 E:385 ||| JJ
animal  ||| S:385 E:392 ||| NN
behavioural  ||| S:392 E:404 ||| NN
analyses  ||| S:404 E:413 ||| NNS
in  ||| S:413 E:416 ||| IN
the  ||| S:416 E:420 ||| DT
ZnT3  ||| S:420 E:425 ||| NNP
KO  ||| S:425 E:428 ||| NNP
mouse  ||| S:428 E:434 ||| NN
line ||| S:434 E:438 ||| NN
,  ||| S:438 E:440 ||| ,
together  ||| S:440 E:449 ||| RB
with  ||| S:449 E:454 ||| IN
electrophysiological  ||| S:454 E:475 ||| JJ
analysis  ||| S:475 E:484 ||| NN
of  ||| S:484 E:487 ||| IN
long-term  ||| S:487 E:497 ||| JJ
potentiation  ||| S:497 E:510 ||| NN
in  ||| S:510 E:513 ||| IN
brain  ||| S:513 E:519 ||| NN
slices  ||| S:519 E:526 ||| NN
from  ||| S:526 E:531 ||| IN
ZnT3  ||| S:531 E:536 ||| NNP
KO  ||| S:536 E:539 ||| NNP
mice ||| S:539 E:543 ||| NNS
,  ||| S:543 E:545 ||| ,
to  ||| S:545 E:548 ||| TO
show  ||| S:548 E:553 ||| VB
that  ||| S:553 E:558 ||| DT
metal  ||| S:558 E:564 ||| NN
chaperones  ||| S:564 E:575 ||| NNS
( ||| S:575 E:576 ||| -LRB-
clioquinol ||| S:576 E:586 ||| UH
,  ||| S:586 E:588 ||| ,
30  ||| S:588 E:591 ||| CD
mg ||| S:591 E:593 ||| CD
/ ||| S:593 E:594 ||| CD
kg ||| S:594 E:596 ||| CD
/ ||| S:596 E:597 ||| CD
day  ||| S:597 E:601 ||| NN
for  ||| S:601 E:605 ||| IN
6weeks ||| S:605 E:611 ||| CD
)  ||| S:611 E:613 ||| -RRB-
can  ||| S:613 E:617 ||| MD
prevent  ||| S:617 E:625 ||| VB
the  ||| S:625 E:629 ||| DT
age-dependent  ||| S:629 E:643 ||| JJ
cognitive  ||| S:643 E:653 ||| JJ
phenotype  ||| S:653 E:663 ||| NN
that  ||| S:663 E:668 ||| IN
characterises  ||| S:668 E:682 ||| VBG
these  ||| S:682 E:688 ||| DT
animals ||| S:688 E:695 ||| NNS
.  ||| S:695 E:697 ||| .
This  ||| S:697 E:702 ||| DT
likely  ||| S:702 E:709 ||| JJ
occurs  ||| S:709 E:716 ||| NN
as  ||| S:716 E:719 ||| IN
a  ||| S:719 E:721 ||| DT
result  ||| S:721 E:728 ||| NN
of  ||| S:728 E:731 ||| IN
a  ||| S:731 E:733 ||| DT
homeostatic  ||| S:733 E:745 ||| JJ
restoration  ||| S:745 E:757 ||| NN
of  ||| S:757 E:760 ||| IN
synaptic  ||| S:760 E:769 ||| JJ
protein  ||| S:769 E:777 ||| NN
expression ||| S:777 E:787 ||| NN
,  ||| S:787 E:789 ||| ,
as  ||| S:789 E:792 ||| RB
clioquinol  ||| S:792 E:803 ||| VBN
significantly  ||| S:803 E:817 ||| RB
restored  ||| S:817 E:826 ||| VBN
levels  ||| S:826 E:833 ||| NNS
of  ||| S:833 E:836 ||| IN
various  ||| S:836 E:844 ||| JJ
pre-  ||| S:844 E:849 ||| JJ
and  ||| S:849 E:853 ||| CC
postsynaptic  ||| S:853 E:866 ||| JJ
proteins  ||| S:866 E:875 ||| NNS
that  ||| S:875 E:880 ||| WDT
are  ||| S:880 E:884 ||| VBP
critical  ||| S:884 E:893 ||| JJ
for  ||| S:893 E:897 ||| IN
normal  ||| S:897 E:904 ||| JJ
cognition ||| S:904 E:913 ||| NN
,  ||| S:913 E:915 ||| ,
including  ||| S:915 E:925 ||| VBG
PSD-95 ||| S:925 E:931 ||| CD
;  ||| S:931 E:933 ||| :
AMPAR  ||| S:933 E:939 ||| NNP
and  ||| S:939 E:943 ||| CC
NMDAR2b ||| S:943 E:950 ||| NNP
.  ||| S:950 E:952 ||| .
We  ||| S:952 E:955 ||| PRP
hypothesised  ||| S:955 E:968 ||| VBD
that  ||| S:968 E:973 ||| IN
this  ||| S:973 E:978 ||| DT
clioquinol-mediated  ||| S:978 E:998 ||| JJ
restoration  ||| S:998 E:1010 ||| NN
of  ||| S:1010 E:1013 ||| IN
synaptic  ||| S:1013 E:1022 ||| JJ
health  ||| S:1022 E:1029 ||| NN
resulted  ||| S:1029 E:1038 ||| VBD
from  ||| S:1038 E:1043 ||| IN
a  ||| S:1043 E:1045 ||| DT
selective  ||| S:1045 E:1055 ||| JJ
increase  ||| S:1055 E:1064 ||| NN
in  ||| S:1064 E:1067 ||| IN
synaptic  ||| S:1067 E:1076 ||| JJ
zinc  ||| S:1076 E:1081 ||| NN
content  ||| S:1081 E:1089 ||| NN
within  ||| S:1089 E:1096 ||| IN
the  ||| S:1096 E:1100 ||| DT
hippocampus ||| S:1100 E:1111 ||| NN
.  ||| S:1111 E:1113 ||| .
While  ||| S:1113 E:1119 ||| IN
we  ||| S:1119 E:1122 ||| PRP
demonstrated  ||| S:1122 E:1135 ||| VBD
a  ||| S:1135 E:1137 ||| DT
small  ||| S:1137 E:1143 ||| JJ
regional  ||| S:1143 E:1152 ||| JJ
increase  ||| S:1152 E:1161 ||| NN
in  ||| S:1161 E:1164 ||| IN
hippocampal  ||| S:1164 E:1176 ||| FW
zinc  ||| S:1176 E:1181 ||| FW
content  ||| S:1181 E:1189 ||| FW
using  ||| S:1189 E:1195 ||| FW
synchrotron  ||| S:1195 E:1207 ||| FW
x-ray  ||| S:1207 E:1213 ||| FW
fluorescence  ||| S:1213 E:1226 ||| FW
microscopy ||| S:1226 E:1236 ||| FW
,  ||| S:1236 E:1238 ||| ,
further  ||| S:1238 E:1246 ||| RB
sub-region  ||| S:1246 E:1257 ||| JJ
analyses  ||| S:1257 E:1266 ||| NNS
are  ||| S:1266 E:1270 ||| VBP
required  ||| S:1270 E:1279 ||| VBN
to  ||| S:1279 E:1282 ||| TO
determine  ||| S:1282 E:1292 ||| VB
whether  ||| S:1292 E:1300 ||| IN
this  ||| S:1300 E:1305 ||| DT
effect  ||| S:1305 E:1312 ||| NN
is  ||| S:1312 E:1315 ||| VBZ
seen  ||| S:1315 E:1320 ||| VBN
in  ||| S:1320 E:1323 ||| IN
other  ||| S:1323 E:1329 ||| JJ
regions  ||| S:1329 E:1337 ||| NNS
of  ||| S:1337 E:1340 ||| IN
the  ||| S:1340 E:1344 ||| DT
hippocampal  ||| S:1344 E:1356 ||| JJ
formation  ||| S:1356 E:1366 ||| NN
that  ||| S:1366 E:1371 ||| WDT
are  ||| S:1371 E:1375 ||| VBP
more  ||| S:1375 E:1380 ||| RBR
closely  ||| S:1380 E:1388 ||| RB
linked  ||| S:1388 E:1395 ||| VBN
to  ||| S:1395 E:1398 ||| TO
the  ||| S:1398 E:1402 ||| DT
synaptic  ||| S:1402 E:1411 ||| JJ
plasticity  ||| S:1411 E:1422 ||| JJ
effects  ||| S:1422 E:1430 ||| NNS
observed  ||| S:1430 E:1439 ||| VBD
in  ||| S:1439 E:1442 ||| IN
this  ||| S:1442 E:1447 ||| DT
study ||| S:1447 E:1452 ||| NN
.  ||| S:1452 E:1454 ||| .
These  ||| S:1454 E:1460 ||| DT
data  ||| S:1460 E:1465 ||| NNS
support  ||| S:1465 E:1473 ||| VBP
our  ||| S:1473 E:1477 ||| PRP$
recent  ||| S:1477 E:1484 ||| JJ
report  ||| S:1484 E:1491 ||| NN
on  ||| S:1491 E:1494 ||| IN
the  ||| S:1494 E:1498 ||| DT
use  ||| S:1498 E:1502 ||| NN
of  ||| S:1502 E:1505 ||| IN
a  ||| S:1505 E:1507 ||| DT
different  ||| S:1507 E:1517 ||| JJ
metal  ||| S:1517 E:1523 ||| NN
chaperone  ||| S:1523 E:1533 ||| NNS
( ||| S:1533 E:1534 ||| -LRB-
PBT2 ||| S:1534 E:1538 ||| NNP
)  ||| S:1538 E:1540 ||| -RRB-
to  ||| S:1540 E:1543 ||| TO
prevent  ||| S:1543 E:1551 ||| VB
normal  ||| S:1551 E:1558 ||| JJ
age-related  ||| S:1558 E:1570 ||| JJ
cognitive  ||| S:1570 E:1580 ||| JJ
decline  ||| S:1580 E:1588 ||| NN
and  ||| S:1588 E:1592 ||| CC
demonstrate  ||| S:1592 E:1604 ||| VB
that  ||| S:1604 E:1609 ||| DT
metal  ||| S:1609 E:1615 ||| NN
chaperones  ||| S:1615 E:1626 ||| NNS
are  ||| S:1626 E:1630 ||| VBP
efficacious  ||| S:1630 E:1642 ||| VBN
in  ||| S:1642 E:1645 ||| IN
preventing  ||| S:1645 E:1656 ||| VBG
the  ||| S:1656 E:1660 ||| DT
zinc-mediated  ||| S:1660 E:1674 ||| JJ
cognitive  ||| S:1674 E:1684 ||| JJ
decline  ||| S:1684 E:1692 ||| NN
that  ||| S:1692 E:1697 ||| IN
characterises  ||| S:1697 E:1711 ||| JJ
ageing  ||| S:1711 E:1718 ||| NN
and  ||| S:1718 E:1722 ||| CC
disease ||| S:1722 E:1729 ||| NN
.  ||| S:1729 E:1731 ||| .
